In
Situ Hybridization
The Molecular Histology Center
(MHC) performs both isotopic and nonisotopic in situ hybridization histochemistry.
This is a method for detecting the expression of mRNA in tissue sections.
Both quantitative and qualitative analyses can be performed. Two types
of probes can be used, short DNA oligonucleotides (typically 48 bp)
or longer length RNA or DNA probes. The choice of optimal probe and
detection method are made based on the needs of an experiment.
The technique of in situ
hybridization histochemistry demands rigor and commitment to perform
well. It is not a technique one would necessarily want to implement
for a single experiment or a small set of experiments. The MHC performs
this technique routinely and has the experience, reagents, and equipment
to efficiently apply this technique. However, with all molecular and
tissue-based assays testing and development are required. The MHC has
a series of assurances and quality control steps that assist in the
process of assay development including testing the quality of probe
labeling and tissue.
The cost of in situ hybridization
is based on the type of the probe used, the number of probes examined,
the number of conditions and testing required, the number of slides,
and choice of detection method and analyses. With the use of a worksheet
we can assist with generating a cost estimate for your project.
Services provided include consultation about your experiment, oligonucleotide
design, oligonucleotide purchase, oligonucleotide dissolving at stock
and working concentrations, tissue acquisition and sectioning, probe
labeling, purification, and determination of specific activity, tissue
hybridization, film or phosphor screen exposure, densitometry, emulsion
dipping, grain counting, and image capture. Our specific services are
reviewed on Services
Page.
Specific methods for various
techniques can be downloaded for use with grant applications or publications.